CMAC Core project: Impurity Rejection

Florence, Alastair (Principal Investigator)
Ter Horst, Joop (Co-investigator)

Project: Research

Status	Finished
Effective start/end date	1/10/17 → 30/09/19

Funding

Takeda Pharmaceutical Company Ltd
F Hoffmann La Roche Ltd
Eli Lilly and Company
Astra Zeneca
Glaxo Smithkline (UK)
Novartis Pharma AG
Bayer Healthcare AG
F Hoffmann La Roche Ltd
Eli Lilly and Company
Pfizer Inc US
Astra Zeneca
Glaxo Smithkline (UK)
Novartis Pharma AG
Bayer Healthcare AG